ChemoCentryx (CCXI) Prices 5.2M Share Common Offering at $58/Sh

ChemoCentryx, Inc. (NASDAQ: CCXI) announced today that it has priced an underwritten public offering of 5,200,000 shares of its common stock at a price to the public of $58.00 per share. The gross proceeds to ChemoCentryx from the offering, before underwriting discounts and commissions and offering costs, are expected to be $301,600,000. ChemoCentryx has granted the underwriters a 30-day option to purchase up to an additional 780,000 shares of its common stock on the same terms and conditions. All shares of the common stock to be sold in the offering will be offered by ChemoCentryx. The offering is expected to close on June 15, 2020, subject to satisfaction of customary closing conditions.

SVB Leerink and Piper Sandler are acting as joint lead bookrunning managers for the offering, Canaccord Genuity and Raymond James are acting as passive joint bookrunning managers for the offering and H.C. Wainwright & Co. is acting as lead manager for the offering.

You May Also Be Interested In

• Pershing Square Selling About 80.6m Shares In Universal Music - Bloomberg
• SpaceX files for 555.56M share IPO at $135/sh
• Central Asia Metals agrees to acquire Cygnus Metals for A$232 million